171 related articles for article (PubMed ID: 12594633)
1. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
[TBL] [Abstract][Full Text] [Related]
2. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
5. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia.
Taylor WR; Richie TL; Fryauff DJ; Picarima H; Ohrt C; Tang D; Braitman D; Murphy GS; Widjaja H; Tjitra E; Ganjar A; Jones TR; Basri H; Berman J
Clin Infect Dis; 1999 Jan; 28(1):74-81. PubMed ID: 10028075
[TBL] [Abstract][Full Text] [Related]
6. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
Baird JK; Lacy MD; Basri H; Barcus MJ; Maguire JD; Bangs MJ; Gramzinski R; Sismadi P; Krisin ; Ling J; Wiady I; Kusumaningsih M; Jones TR; Fryauff DJ; Hoffman SL;
Clin Infect Dis; 2001 Dec; 33(12):1990-7. PubMed ID: 11712091
[TBL] [Abstract][Full Text] [Related]
7. Malaria chemoprophylaxis with tafenoquine: a randomised study.
Lell B; Faucher JF; Missinou MA; Borrmann S; Dangelmaier O; Horton J; Kremsner PG
Lancet; 2000 Jun; 355(9220):2041-5. PubMed ID: 10885356
[TBL] [Abstract][Full Text] [Related]
8. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
Dow GS; Liu J; Lin G; Hetzell B; Thieling S; McCarthy WF; Tang D; Smith B
Malar J; 2015 Nov; 14():473. PubMed ID: 26610844
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial.
Villegas L; McGready R; Htway M; Paw MK; Pimanpanarak M; Arunjerdja R; Viladpai-Nguen SJ; Greenwood B; White NJ; Nosten F
Trop Med Int Health; 2007 Feb; 12(2):209-18. PubMed ID: 17300627
[TBL] [Abstract][Full Text] [Related]
11. Primaquine for prevention of malaria in travelers.
Baird JK; Fryauff DJ; Hoffman SL
Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
[TBL] [Abstract][Full Text] [Related]
13. Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.
Heppner DG; Walsh DS; Uthaimongkol N; Tang DB; Tulyayon S; Permpanich B; Wimonwattrawatee T; Chuanak N; Laoboonchai A; Sookto P; Brewer TG; McDaniel P; Eamsila C; Yongvanitchit K; Uhl K; Kyle DE; Keep LW; Miller RE; Wongsrichanalai C
Am J Trop Med Hyg; 2005 Nov; 73(5):842-9. PubMed ID: 16282291
[TBL] [Abstract][Full Text] [Related]
14. Blood Schizonticidal Activity and Safety of Tafenoquine When Administered as Chemoprophylaxis to Healthy, Nonimmune Participants Followed by Blood Stage Plasmodium falciparum Challenge: A Randomized, Double-blind, Placebo-controlled Phase 1b Study.
McCarthy JS; Smith B; Reid M; Berman J; Marquart L; Dobbin C; West L; Read LT; Dow GS
Clin Infect Dis; 2019 Jul; 69(3):480-486. PubMed ID: 30388194
[TBL] [Abstract][Full Text] [Related]
15. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.
Leary KJ; Riel MA; Roy MJ; Cantilena LR; Bi D; Brater DC; van de Pol C; Pruett K; Kerr C; Veazey JM; Beboso R; Ohrt C
Am J Trop Med Hyg; 2009 Aug; 81(2):356-62. PubMed ID: 19635898
[TBL] [Abstract][Full Text] [Related]
17. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children.
Fernando D; de Silva D; Carter R; Mendis KN; Wickremasinghe R
Am J Trop Med Hyg; 2006 Mar; 74(3):386-93. PubMed ID: 16525095
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia.
Yang H; Wang J; Liu H; Li X; Nie R; Li C; Wang H; Wang Q; Cao Y; Cui L
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
